This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter          
HOPE LOGO

Oncology

Warning as skin cancer rates double in 20 years
Warning as skin cancer rates double in 20 years
Read more
Spectrila enters the UK market for the treatment of acute lymphoblastic leukaemia
Spectrila enters the UK market for the treatment of acute lymphoblastic leukaemia
Read more
Neuroendocrine tumour service named as Centre of Excellence
Neuroendocrine tumour service named as Centre of Excellence
Read more
Firmagon® recommended for advanced prostate cancer with spinal metastases
Firmagon® recommended for advanced prostate cancer with spinal metastases
Read more
European Commission approves extended indication for Kyprolis® for relapsed multiple myeloma patients
European Commission approves extended indication for Kyprolis® for relapsed multiple myeloma patients
Read more
Updated NICE quality standard recommends Oncotype DX® in early-stage breast cancer
Updated NICE quality standard recommends Oncotype DX® in early-stage breast cancer
Read more
Meeting cancer promises and more – a new model for NHS diagnostics?
Meeting cancer promises and more – a new model for NHS diagnostics?
Read more
Blincyto® improved overall survival in patients with B-cell precursor acute lymphoblastic leukaemia
Blincyto® improved overall survival in patients with B-cell precursor acute lymphoblastic leukaemia
Read more
Merck partners with Array BioPharma and Pierre Fabre to initiate BRAF-mutant CRC trial
Merck partners with Array BioPharma and Pierre Fabre to initiate BRAF-mutant CRC trial
Read more
Amgen receives positive CHMP opinion to extend indication of Kyprolis®
Amgen receives positive CHMP opinion to extend indication of Kyprolis®
Read more
NICE recommends Jevtana® to treat eligible patients with advanced prostate cancer
NICE recommends Jevtana® to treat eligible patients with advanced prostate cancer
Read more
Latest developments in intravascular robotics
Read more
A novel therapy for high-grade glioma
Read more
AbbVie announces The Lancet Oncology publication of Phase II data for Venetoclax
AbbVie announces The Lancet Oncology publication of Phase II data for Venetoclax
Read more
Managing chemotherapy extravasations in practice
Read more
Urine FISH for detection of urothelial cancer
Read more
MALDI-MSI: a powerful tool in cancer research
Read more

Popular articles

Does cancer screening actually reduce all-cause mortality?
Stress and high workload confirmed as main reasons staff leave NHS
Ruxolitinib approved by NICE for treatment of polycythaemia vera





 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
×